chemotherapy: be administered

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be administered 1.00
is administered 1.00
be administered to patient 0.90
be administered in cycles 0.88
be administered to lymphoma patient 0.80

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.04
Rule weight: 0.13
Evidence weight: 0.30
Similarity weight: 0.90
Evidence: 0.87
¬ Remarkable(chemotherapy, be administered) ⋁
Evidence: 0.81
¬ Remarkable(gene therapy, be administered to patient)

Remarkability from sibling implausibility

0.51
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.90
Evidence: 0.21
Plausible(chemotherapy, be administered) ⋁
Evidence: 0.81
Remarkable(gene therapy, be administered to patient) ⋁
Evidence: 0.38
¬ Plausible(gene therapy, be administered to patient)

Salient implies Plausible

0.20
Rule weight: 0.28
Evidence weight: 0.70
Similarity weight: 1.00
Evidence: 0.21
Plausible(chemotherapy, be administered) ⋁
Evidence: 0.38
¬ Salient(chemotherapy, be administered)

Similarity expansion

0.82
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.07
Typical(chemotherapy, be administered) ⋁
Evidence: 0.04
¬ Typical(chemotherapy, is administered)
0.75
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.87
Remarkable(chemotherapy, be administered) ⋁
Evidence: 0.95
¬ Remarkable(chemotherapy, is administered)
0.72
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.88
Evidence: 0.87
Remarkable(chemotherapy, be administered) ⋁
Evidence: 0.34
¬ Remarkable(chemotherapy, be administered in cycles)
0.70
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 1.00
Evidence: 0.21
Plausible(chemotherapy, be administered) ⋁
Evidence: 0.22
¬ Plausible(chemotherapy, is administered)
0.67
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.88
Evidence: 0.21
Plausible(chemotherapy, be administered) ⋁
Evidence: 0.14
¬ Plausible(chemotherapy, be administered in cycles)
0.66
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.88
Evidence: 0.38
Salient(chemotherapy, be administered) ⋁
Evidence: 0.20
¬ Salient(chemotherapy, be administered in cycles)
0.62
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.80
Evidence: 0.87
Remarkable(chemotherapy, be administered) ⋁
Evidence: 0.68
¬ Remarkable(chemotherapy, be administered to lymphoma patient)
0.61
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.88
Evidence: 0.07
Typical(chemotherapy, be administered) ⋁
Evidence: 0.20
¬ Typical(chemotherapy, be administered in cycles)
0.61
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 1.00
Evidence: 0.38
Salient(chemotherapy, be administered) ⋁
Evidence: 0.46
¬ Salient(chemotherapy, is administered)
0.31
Rule weight: 0.85
Evidence weight: 0.45
Similarity weight: 0.80
Evidence: 0.38
Salient(chemotherapy, be administered) ⋁
Evidence: 0.88
¬ Salient(chemotherapy, be administered to lymphoma patient)
0.25
Rule weight: 0.85
Evidence weight: 0.37
Similarity weight: 0.80
Evidence: 0.21
Plausible(chemotherapy, be administered) ⋁
Evidence: 0.80
¬ Plausible(chemotherapy, be administered to lymphoma patient)
0.15
Rule weight: 0.85
Evidence weight: 0.23
Similarity weight: 0.80
Evidence: 0.07
Typical(chemotherapy, be administered) ⋁
Evidence: 0.83
¬ Typical(chemotherapy, be administered to lymphoma patient)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.38
Salient(chemotherapy, be administered) ⋁
Evidence: 0.07
¬ Typical(chemotherapy, be administered) ⋁
Evidence: 0.87
¬ Remarkable(chemotherapy, be administered)

Typical implies Plausible

0.45
Rule weight: 0.48
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.21
Plausible(chemotherapy, be administered) ⋁
Evidence: 0.07
¬ Typical(chemotherapy, be administered)

Typicality and Rermarkability incompatibility between siblings

0.09
Rule weight: 0.14
Evidence weight: 0.77
Similarity weight: 0.90
Evidence: 0.87
¬ Remarkable(chemotherapy, be administered) ⋁
Evidence: 0.27
¬ Typical(gene therapy, be administered to patient)